Does ANTX or ORMP pay a bigger dividend?

ORMP pays a dividend (5.59% yield), while ANTX is a former payer with no current dividend run rate.

Is ANTX or ORMP more profitable?

ORMP runs the higher net margin — ANTX at 0.00% versus ORMP at 3202.50%.

AN2 Therapeutics, Inc. (ANTX) vs Oramed Pharmaceuticals Inc. (ORMP)

A side-by-side comparison of AN2 Therapeutics, Inc. and Oramed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANTX

AN2 Therapeutics, Inc.

$183M

$5.07HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

ORMP

Oramed Pharmaceuticals Inc.

$179M

$4.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ANTX vs ORMP

growth of $100 · dividends reinvested · last 5y

ANTX -63.6% (-18.3%/yr)ORMP -47.9% (-12.2%/yr)ORMP compounded faster over this window

ANTX ORMP

ANTX vs ORMP: by the numbers

•ANTX is the larger company ($183M vs $179M market cap).
•ORMP is profitable (3202.50% net margin) while ANTX runs a net loss (0.00%).
•ORMP pays a dividend (5.59% yield), while ANTX is a former payer with no current dividend run rate.

Metrics side by side

Valuation

Metric	ANTX	ORMP
P/E ratio	N/A	1.07
P/B ratio	2.41	0.56

Profitability

Metric	ANTX	ORMP
Gross margin	0.00%	0.65%
Operating margin	0.00%	-754.40%
Net margin	0.00%	3202.50%
ROE	-47.78%	55.08%
ROIC	-51.01%	-3.21%

Dividends

Metric	ANTX	ORMP
Dividend yield	N/A	5.59%
Payout ratio	N/A	6.08%

Growth (annualized)

Metric	ANTX	ORMP
Total return CAGR (5Y)	N/A	-25.80%

Frequently asked

Does ANTX or ORMP pay a bigger dividend?: ORMP pays a dividend (5.59% yield), while ANTX is a former payer with no current dividend run rate.
Is ANTX or ORMP more profitable?: ORMP runs the higher net margin — ANTX at 0.00% versus ORMP at 3202.50%.

Go deeper

Full ANTX analysis Full ORMP analysis Interactive comparison tool

Dig into the metrics

Oramed Pharmaceuticals P/E ratio Oramed Pharmaceuticals dividend yield AN2 Therapeutics ROE Oramed Pharmaceuticals ROE AN2 Therapeutics operating margin Oramed Pharmaceuticals operating margin AN2 Therapeutics revenue growth Oramed Pharmaceuticals revenue growth AN2 Therapeutics free cash flow Oramed Pharmaceuticals free cash flow

AN2 Therapeutics & Oramed Pharmaceuticals appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.